Chemoinformaics analysis of 4-Methoxy-9,10-dihydrophenanthrene-2,7-diol
| Molecular Weight | 242.274 | nRot | 1 |
| Heavy Atom Molecular Weight | 228.162 | nRig | 16 |
| Exact Molecular Weight | 242.094 | nRing | 3 |
| Solubility: LogS | -3.372 | nHRing | 0 |
| Solubility: LogP | 3.066 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
| nHA | 3 | APOL | 36.7911 |
| nHD | 2 | BPOL | 15.7809 |
| QED | 0.808 |
| Synth | 2.271 |
| Natural Product Likeliness | 1.48 |
| NR-PPAR-gamma | 0.612 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.054 |
| Pgp-sub | 0.193 |
| HIA | 0.005 |
| CACO-2 | -4.82 |
| MDCK | 0.0000148 |
| BBB | 0.205 |
| PPB | 0.876569 |
| VDSS | 1.249 |
| FU | 0.0526756 |
| CYP1A2-inh | 0.968 |
| CYP1A2-sub | 0.907 |
| CYP2c19-inh | 0.668 |
| CYP2c19-sub | 0.08 |
| CYP2c9-inh | 0.299 |
| CYP2c9-sub | 0.948 |
| CYP2d6-inh | 0.921 |
| CYP2d6-sub | 0.93 |
| CYP3a4-inh | 0.869 |
| CYP3a4-sub | 0.204 |
| CL | 11.846 |
| T12 | 0.708 |
| hERG | 0.133 |
| Ames | 0.408 |
| ROA | 0.115 |
| SkinSen | 0.839 |
| Carcinogencity | 0.065 |
| EI | 0.929 |
| Respiratory | 0.292 |
| NR-Aromatase | 0.534 |
| Antiviral | No |
| Prediction | 0.548567 |